Literature DB >> 17383306

A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems.

Christophe Bauters1, Nicolas Lamblin, Pierre V Ennezat, Christophe Mycinski, Olivier Tricot, Olivier Nugue, Benoit Segrestin, Gery Hannebicque, Benaissa Agraou, Anne Sophie Polge, Pascal de Groote, Nicole Helbecque, Philippe Amouyel.   

Abstract

BACKGROUND: Left ventricular remodeling (LVR) is a strong predictor of cardiovascular events after myocardial infarction (MI). Although several factors have been shown to influence LVR, interindividual variability exists. Some studies have suggested that gene polymorphisms may be associated with LVR, but these studies were limited by either a retrospective design or the inclusion of limited patient numbers. The present study was designed to prospectively assess the impact of gene polymorphisms on LVR.
METHODS: We included 266 patients with inaugural anterior MI. Systematic echocardiographic follow-ups were performed at 3 months and at 1 year after MI. The polymorphisms were selected using a candidate gene approach based on LVR pathophysiology. We analyzed 14 polymorphisms in 3 different systems: the renin-angiotensin-aldosterone system (ACE I/D, RAT1 1166A/C, angiotensinogen M235T, CYP11B2 -344C/T), the adrenergic system (beta1AR Ser49Gly, beta1AR Gly389Arg, beta2AR Gly16Arg, beta2AR Gln27Glu, beta2AR Thr164Ile, alpha2cAR Del322-325), and the metalloproteinase (MMP) system (-1607 1G/2G MMP-1, -1306 C/T MMP-2, -1171 5A/6A MMP-3, -1562 C/T MMP-9).
RESULTS: Left ventricular remodeling was documented by a progressive increase in end-diastolic volume from 56.5 +/- 14.9 mL/m2 at baseline to 62.8 +/- 18.8 mL/m2 at 1 year (P < .0001). End-diastolic volume at baseline, 3 months, or 1 year did not differ significantly among genotypes for any polymorphism. The change in end-diastolic volume from baseline to 1 year was also similar among genotypes for all polymorphisms.
CONCLUSIONS: Left ventricular remodeling after MI is not associated with common polymorphisms in the renin-angiotensin-aldosterone, adrenergic, or MMP systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383306     DOI: 10.1016/j.ahj.2007.01.009

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.

Authors:  R Panovsky; A Vasku; J Meluzin; M Kaminek; J Mayer; S Janousek; V Kincl; L Groch; M Navratil
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

Review 2.  Left Ventricular Remodelling: A Problem in Search of Solutions.

Authors:  Dennis V Cokkinos; Christos Belogianneas
Journal:  Eur Cardiol       Date:  2016-08

3.  Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.

Authors:  Chris Watson; J Paul Spiers; Max Waterstone; Adam Russell-Hallinan; Joseph Gallagher; Kenneth McDonald; Cristin Ryan; John Gilmer; Mark Ledwidge
Journal:  BMC Cardiovasc Disord       Date:  2021-02-12       Impact factor: 2.298

Review 4.  Structural aspects of Golgi function.

Authors:  R S Polishchuk; A A Mironov
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

5.  The link between apolipoprotein E, presenilin 1, and kinesin light chain 1 gene polymorphisms and age-related cortical cataracts in the Chinese population.

Authors:  Min Wu; Can Zheng; Rong-Di Yuan; Min Sun; Yan Xu; Jian Ye
Journal:  Mol Vis       Date:  2015-04-10       Impact factor: 2.367

6.  Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.

Authors:  Christophe Bauters; Emilie Dubois; Sina Porouchani; Eric Saloux; Marie Fertin; Pascal de Groote; Nicolas Lamblin; Florence Pinet
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.